Engineered bacteria for augmented in situ tumor vaccination.
Sign Up to like & getrecommendations! Published in 2023 at "Biomaterials science"
DOI: 10.1039/d2bm01593e
Abstract: In situ tumor vaccination has aroused tremendous interest with its capability for eliciting strong and systemic antitumor immune responses. Unlike traditional cancer vaccines, in situ tumor vaccination avoids the laborious process of tumor antigen identification… read more here.
Keywords: bacteria augmented; vaccination; tumor vaccination; engineered bacteria ... See more keywords